GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » PT Kimia Farma Tbk (ISX:KAEF) » Definitions » Gross Profit

PT Kimia Farma Tbk (ISX:KAEF) Gross Profit : Rp2,637,580 Mil (TTM As of Sep. 2024)


View and export this data going back to 2001. Start your Free Trial

What is PT Kimia Farma Tbk Gross Profit?

PT Kimia Farma Tbk's gross profit for the three months ended in Sep. 2024 was Rp773,933 Mil. PT Kimia Farma Tbk's gross profit for the trailing twelve months (TTM) ended in Sep. 2024 was Rp2,637,580 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. PT Kimia Farma Tbk's gross profit for the three months ended in Sep. 2024 was Rp773,933 Mil. PT Kimia Farma Tbk's Revenue for the three months ended in Sep. 2024 was Rp2,650,569 Mil. Therefore, PT Kimia Farma Tbk's Gross Margin % for the quarter that ended in Sep. 2024 was 29.20%.

PT Kimia Farma Tbk had a gross margin of 29.20% for the quarter that ended in Sep. 2024 => Competition eroding margins

During the past 13 years, the highest Gross Margin % of PT Kimia Farma Tbk was 40.92%. The lowest was 26.08%. And the median was 35.06%.

Warning Sign:

PT Kimia Farma Tbk gross margin has been in long-term decline. The average rate of decline per year is -2.8%.


PT Kimia Farma Tbk Gross Profit Historical Data

The historical data trend for PT Kimia Farma Tbk's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Kimia Farma Tbk Gross Profit Chart

PT Kimia Farma Tbk Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,503,287.69 3,657,131.19 4,396,285.10 3,778,425.70 3,101,850.82

PT Kimia Farma Tbk Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 989,187.31 283,963.78 820,837.06 758,846.04 773,933.18

Competitive Comparison of PT Kimia Farma Tbk's Gross Profit

For the Medical Distribution subindustry, PT Kimia Farma Tbk's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Kimia Farma Tbk's Gross Profit Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, PT Kimia Farma Tbk's Gross Profit distribution charts can be found below:

* The bar in red indicates where PT Kimia Farma Tbk's Gross Profit falls into.


;
;

PT Kimia Farma Tbk Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

PT Kimia Farma Tbk's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=9965033.049 - 6863182.228
=3,101,851

PT Kimia Farma Tbk's Gross Profit for the quarter that ended in Sep. 2024 is calculated as

Gross Profit (Q: Sep. 2024 )=Revenue - Cost of Goods Sold
=2650568.513 - 1876635.332
=773,933

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp2,637,580 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

PT Kimia Farma Tbk's Gross Margin % for the quarter that ended in Sep. 2024 is calculated as

Gross Margin % (Q: Sep. 2024 )=Gross Profit (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=773,933 / 2650568.513
=29.20 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


PT Kimia Farma Tbk  (ISX:KAEF) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

PT Kimia Farma Tbk had a gross margin of 29.20% for the quarter that ended in Sep. 2024 => Competition eroding margins


PT Kimia Farma Tbk Gross Profit Related Terms

Thank you for viewing the detailed overview of PT Kimia Farma Tbk's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Kimia Farma Tbk Business Description

Traded in Other Exchanges
N/A
Address
Jalan Veteran No. 9 Gambir, Jakarta Pusat, Jakarta, IDN, 10110
PT Kimia Farma Tbk is an Indonesia-based company engaged in the production and distribution of healthcare products. It operates through the following segments: Manufacture, Distribution, Retail, and Others. The company provides its products in categories including OTC & Herb, Ethical, Cosmetic, Generic, and others. Some of its product offerings include Alergine, Kimoxil, Loprezol, Enkasari, and Batugin among others. It generates maximum revenue from the Retail segment.

PT Kimia Farma Tbk Headlines

No Headlines